CMS' MolDX expands Medicare coverage of Personalis NeXT Personal MRD test to immunotherapy monitoring in late-stage solid tumors
https://finviz.com/quote?t=PSNL&p=d
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.